---
title: "MiniMed (MMED.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MMED.US/norm.md"
symbol: "MMED.US"
name: "MiniMed"
parent: "https://longbridge.com/en/quote/MMED.US.md"
datetime: "2026-03-10T23:40:48.607Z"
locales:
  - [en](https://longbridge.com/en/quote/MMED.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MMED.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MMED.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/MMED.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MMED.US/norm.md)


# MiniMed (MMED.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- |
| EPS | - | - | - | - |
| ROE | -1.63% | - | - | - |
| Revenue | 737.50M | 737.50M | 652.00M | 652.00M |
| Net income | -14.50M | -14.50M | -15.50M | -15.50M |
| Operating income | 10.00M | 10.00M | -10.50M | -10.50M |
| Gross margin | 56.81% | 56.81% | 55.75% | 55.75% |
| Net margin | -1.97% | -1.97% | -2.38% | -2.38% |
| Profit quality | -21.51% | -21.51% | -63.64% | -63.64% |

## Balance Sheet (USD)

| Indicator | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- |
| A&L | 4.29B | 4.29B | - | - |
| Leverage | 1.20 | 1.20 | - | - |
| BVPS | - | - | - | - |
| Turnover | - | - | - | - |
| Cash & STI | 8.00M | 8.00M | - | 54.00M |
| Inv & Rec | 361.00M | 361.00M | - | - |
| LT assets | 818.00M | 818.00M | - | - |
| Net debt | 55.00M | 55.00M | - | -5.00M |

## Cash Flow Statement (USD)

| Indicator | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- |
| Operating CF | -46.50M | -46.50M | 16.50M | 16.50M |
| Investing CF | -62.00M | -62.00M | -43.00M | -43.00M |
| Financing CF | 107.50M | 107.50M | 5.00M | 5.00M |
| Free CF | 1.75M | - | - | - |
| OCF coverage | -81.58% | -81.58% | 38.37% | 38.37% |
| Repaid & issued | - | - | - | - |
| CapEx | -57.00M | -57.00M | -43.00M | -43.00M |